Scientific article
Meta-analysis
OA Policy
English

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system

Published inBMC musculoskeletal disorders, vol. 9, 165
Publication date2008
Abstract

BACKGROUND: Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA). METHODS: The following interventions were taken into consideration: avocado/soybean unsaponifiables, chondroitin sulfate, diacereine, glucosamine sulfate, hyaluronic acid, oral calcitonin, risedronate, strontium ranelate. Recommendations were based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. The GRADE system is based on a sequential assessment of the quality of evidence, followed by assessment of the balance between benefits versus downsides and subsequent judgment about the strength of recommendations. RESULTS: Chondroitin sulfate, diacereine, glucosamine sulfate, avocado/soybean unsaponifiables and hyaluronic acid have demonstrated pain reduction and physical function improvement with very low toxicity, with moderate to high quality evidence. Even if pre-clinical data and some preliminary in vivo studies have suggested that oral calcitonin and strontium ranelate could be of potential interest in OA, additional well-designed studies are needed. CONCLUSION: In the benefit/risk ratio, the use of chondroitin sulfate, diacereine, glucosamine sulfate, avocado/soybean unsaponifiables and hyaluronic acid could be of potential interest for the symptomatic management of OA.

Keywords
  • Anthraquinones/administration & dosage/adverse effects
  • Antirheumatic Agents/*administration & dosage/adverse effects
  • Calcitonin/administration & dosage/adverse effects
  • Chondroitin Sulfates/administration & dosage/adverse effects
  • Clinical Trials as Topic/*statistics & numerical data
  • Etidronic Acid/administration & dosage/adverse effects/analogs & derivatives
  • Glucosamine/administration & dosage/adverse effects
  • Humans
  • Hyaluronic Acid/administration & dosage/adverse effects
  • Organometallic Compounds/administration & dosage/adverse effects
  • Osteoarthritis/*drug therapy
  • Outcome Assessment (Health Care)/methods
  • Plant Extracts/administration & dosage/adverse effects
  • Thiophenes/administration & dosage/adverse effects
Research groups
Citation (ISO format)
BRUYERE, Olivier et al. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. In: BMC musculoskeletal disorders, 2008, vol. 9, p. 165. doi: 10.1186/1471-2474-9-165
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Additional URL for this publicationhttp://www.biomedcentral.com/1471-2474/9/165
Journal ISSN1471-2474
643views
379downloads

Technical informations

Creation27/03/2012 10:58:59
First validation27/03/2012 10:58:59
Update time14/03/2023 18:19:40
Status update14/03/2023 18:19:40
Last indexation29/10/2024 20:10:26
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack